bearish

Chabiotech

CHA Biotech Announces A Capital Raise of 41% of Outstanding Shares

225 Views21 Dec 2024 02:34
This capital raise (250 bn won) by CHA Biotech is likely to negatively impact the company's share price in the next several weeks as many investors are concerned about excessive shares dilution.
What is covered in the Full Insight:
  • Introduction
  • Capital Raise Announcement
  • Impact on Share Price
  • Company Background
  • Key Financials and Valuations
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Top 5%
Douglas Kim
Korea/Asia, Events, IPOs
Douglas Research Advisory
South KoreaEquity Bottom-UpEquity Capital Markets
Price Chart(Sign Up to Access)
analytics-chart
x